**2. Clinical approaches**

Antireflective coatings were developed by taking inspiration from phenomenon of moth's eyes called "Areflexia" which method involved refraction of the light significantly decreasing allows the moth to avoid predators and to see prey in the darkness. Hence, this robotic method is used for various military operations to develop the solar cell light-emitting diodes. Most interesting concept of biomimetic technology is to fabricate optical, electric and electronic properties of nanoparticles by controlling their size and shape by using simple preparatory protocols having less toxicity and trustworthy applications. Bio-inspired technology was found to most promising to develop biodegradable polymeric nanoparticles which can easily

*Biomimetics*

**Research papers**

1 Organism Level,

Behavior Level, Ecosystem Level

2 Ecosystem Level Biomimicry's role in

4 Organism level **Breathing facades**,

3 Organism level Principles have been **used in** 

5 Organism level How termite mounds work

6 Organism level **Analyses mathematical** 

7 Ecosystem Level **Ecosystem based design** 

8 Ecosystem Level A novel **optimization** 

9 Organism level Concept which **deals with** 

10 Ecosystem Level **An ecological replacement** 

relevant analysis of organisms and their respective ecosystems and biodiversity were also studied like their respective functions and associated processes based on exhibited scientific knowledge from biology and ecology. Most recently, biomimetic materials have been synthesized like Se-modified carbon nitride nanosheets, magnesium–strontium hydroxyapatite, dimethylglyoxime–urethane polyurethane, polydimethylsiloxane, Ag/Ag@AgCl/ZnO and PDTC(COOH)4/HA. Applications of biomimetic and biological materials are inevitable in various fields such as biomedical, oil–water separation, sensors, tissue engineering, genome technology

**Categorized under Study focus Highlights**

Achieving more sustainability and **creating a regenerative built environment**

**addressing climate change** in the built environment

**compression structures**

mimicking skin properties of flora and fauna

and application of this concept in building design

**technique** inspired by natural ecosystems

**the ability to collect water, sunlight and wind**

**scheme using traditional concepts** of natural landform, natural orientation and climatic

**theory**

resources.

*Tabular documentation of key Highlights in biomimetic studies (reproduced by Desh SP, 2018) [14].*

**patterns and structures** in biology and nature

Framework is used to discuss various forms of biomimicry as a design methodology. (Realization

Certain ecosystem biomimicry principles for architecture have been

The potential use of tessellation and possibility of a modular building in the micro and macro scale

Enhancing cooling and ventilation systems and achieving thermal comfort

A termite mound is a lung (Realization design, Object

A possibility of use of human bone in structure. Use of fiber reinforced concrete in building to achieve load bearing

A regenerative design approach (Realization

Improving effectiveness of

in the buildings

design)

function.

process)

the user base

Outcome of Living building.

Ecology principles in building design

process)

deduced

**164**

**Table 1.**

circulate through the blood for extended periods of time and also act as detoxification device [17, 18]. By mimicking red blood cells, both physical and chemical biomimicry are integrated to improve the biological function of nanomaterials in-vitro and in-vivo systems. The anisotropic shape and membrane coating are found to synergize for resisting the cellular uptake and reduce clearance from the blood. This approach is observed for enhancing the detoxification of nanoparticles and the anisotropic membrane-coated nanoparticles have enhanced biodistribution and therapeutic efficacy. These biomimetic biodegradable nanodevices and their derivatives have promise for applications ranging from detoxification agents, to drug delivery vehicles, and to biological sensors [19, 20]. High-strength carbon nanotubes (CNTs) were prepared by taking inspirations from "Mussels" called byssi composed of the crosslinking of collagen fibers and a protein known as Mefp-1. This innovative development of high strength was proposed in modern clinical approaches for stitching wounds and successful surgeries. In past decades, various biomimetic technologies have been opted to design the vaccine adjuvants to achieve better immune protection efficiency which could easily mimic the physical and chemical properties of natural pathogens when their interaction is taken place with antigen-presenting cells (APCs) (**Figure 1**).

By mimicking natural pathogens, these particles possess the ability to increase the cellular uptake of antigens, activate APCs, and promote the lysosomal escape of antigens [22]. Newly proposed carriers are synthesized with better biocompatibility, biodistribution and targeting characteristics by taking inspiration biological molecules, organisms, cells, drug vector performances. These prepared protocells are found to exhibited compartmentalized microarchitectures coded with the assembly of protein–polymer nanostructure conjugates used for encapsulation to articulate the proposed design of protein and its related enzymatic activities. The cell-derived biomimetic drug delivery systems are combined with most advantageous synthetic nanoparticles and a natural bio-membrane for providing enhanced efficacy in the treatment of atherosclerosis. The most considerable advantages of this combined system are to provide more options for the design of specific cell membrane coated nano-drugs for imparting good biocompatibility, long course time and inflammatory site targeting. These nanovehicles having protein-based biomimetic nanocarriers have many superior capabilities such as good biocompatibility, low toxicity, low side effects and improved chemotherapy effect. Newly innovated synthetic DNA-based nanoparticles have been synthesized by using biomimetic technology which are found to have full control over the trafficking of internal cargo cellular delivery of loaded compounds to targeting vectors which requires robust endosomal escape from the cellular degradation pathway to facilitate therapeutic mRNA or CRISPR/Cas9 action [23]. These days, the advanced drug delivery methods have been focused for achieving more successful targeted novel drug involving enhanced capacity of drug loading in drug carriers, cellular uptake of drug carriers and the sustained release of loaded drugs to the target cells. Six groups of therapeutic drug carriers are reported which including biomimetic hydrogels, biomimetic micelles, biomimetic liposomes, biomimetic dendrimers, biomimetic polymeric carriers and biomimetic nanostructures. Artificial chemically modified fabrication of biomimetic nanocomposite drug carriers could noticeably deliver the effective targeted concentration of loaded drugs in targeted drug delivery systems. Biomimetic hydrogels have emerged the most promising tissue engineering scaffold materials and their versatile chemistry can sum up various multiple physical and chemical features to integrate cells, scaffolds, and signaling molecules for tissue regeneration. Due to having highly hydrophilic nature hydrogels can design the nutrient-rich aqueous environments for cells and soluble regulatory molecules can be readily incorporated for achieving cell proliferation and differentiation. Novel in-situ

**167**

**Figure 1.**

*(reproduced by lee et al, 2011) [21].*

*(A) Structure of byssi in mussels. (B) Chemical structure of a Dopa-rich mussel foot protein (mfp)* 

*Clinical Approaches of Biomimetic: An Emerging Next Generation Technology*

*DOI: http://dx.doi.org/10.5772/intechopen.97148*

*Clinical Approaches of Biomimetic: An Emerging Next Generation Technology DOI: http://dx.doi.org/10.5772/intechopen.97148*

#### **Figure 1.**

*(A) Structure of byssi in mussels. (B) Chemical structure of a Dopa-rich mussel foot protein (mfp) (reproduced by lee et al, 2011) [21].*

*Biomimetics*

antigen-presenting cells (APCs) (**Figure 1**).

circulate through the blood for extended periods of time and also act as detoxification device [17, 18]. By mimicking red blood cells, both physical and chemical biomimicry are integrated to improve the biological function of nanomaterials in-vitro and in-vivo systems. The anisotropic shape and membrane coating are found to synergize for resisting the cellular uptake and reduce clearance from the blood. This approach is observed for enhancing the detoxification of nanoparticles and the anisotropic membrane-coated nanoparticles have enhanced biodistribution and therapeutic efficacy. These biomimetic biodegradable nanodevices and their derivatives have promise for applications ranging from detoxification agents, to drug delivery vehicles, and to biological sensors [19, 20]. High-strength carbon nanotubes (CNTs) were prepared by taking inspirations from "Mussels" called byssi composed of the crosslinking of collagen fibers and a protein known as Mefp-1. This innovative development of high strength was proposed in modern clinical approaches for stitching wounds and successful surgeries. In past decades, various biomimetic technologies have been opted to design the vaccine adjuvants to achieve better immune protection efficiency which could easily mimic the physical and chemical properties of natural pathogens when their interaction is taken place with

By mimicking natural pathogens, these particles possess the ability to increase the cellular uptake of antigens, activate APCs, and promote the lysosomal escape of antigens [22]. Newly proposed carriers are synthesized with better biocompatibility, biodistribution and targeting characteristics by taking inspiration biological molecules, organisms, cells, drug vector performances. These prepared protocells are found to exhibited compartmentalized microarchitectures coded with the assembly of protein–polymer nanostructure conjugates used for encapsulation to articulate the proposed design of protein and its related enzymatic activities. The cell-derived biomimetic drug delivery systems are combined with most advantageous synthetic nanoparticles and a natural bio-membrane for providing enhanced efficacy in the treatment of atherosclerosis. The most considerable advantages of this combined system are to provide more options for the design of specific cell membrane coated nano-drugs for imparting good biocompatibility, long course time and inflammatory site targeting. These nanovehicles having protein-based biomimetic nanocarriers have many superior capabilities such as good biocompatibility, low toxicity, low side effects and improved chemotherapy effect. Newly innovated synthetic DNA-based nanoparticles have been synthesized by using biomimetic technology which are found to have full control over the trafficking of internal cargo cellular delivery of loaded compounds to targeting vectors which requires robust endosomal escape from the cellular degradation pathway to facilitate therapeutic mRNA or CRISPR/Cas9 action [23]. These days, the advanced drug delivery methods have been focused for achieving more successful targeted novel drug involving enhanced capacity of drug loading in drug carriers, cellular uptake of drug carriers and the sustained release of loaded drugs to the target cells. Six groups of therapeutic drug carriers are reported which including biomimetic hydrogels, biomimetic micelles, biomimetic liposomes, biomimetic dendrimers, biomimetic polymeric carriers and biomimetic nanostructures. Artificial chemically modified fabrication of biomimetic nanocomposite drug carriers could noticeably deliver the effective targeted concentration of loaded drugs in targeted drug delivery systems. Biomimetic hydrogels have emerged the most promising tissue engineering scaffold materials and their versatile chemistry can sum up various multiple physical and chemical features to integrate cells, scaffolds, and signaling molecules for tissue regeneration. Due to having highly hydrophilic nature hydrogels can design the nutrient-rich aqueous environments for cells and soluble regulatory molecules can be readily incorporated for achieving cell proliferation and differentiation. Novel in-situ

**166**

chondroitin sulfate (CS) hydrogel was also synthesized by using phosphine-mediated Michael type addition reaction by adding precursor solutions of CS-acrylate and CS-tri(2-carboxyethyl)phosphine (TCEP) which was thermally stable and biocompatible [24]. The most important is their respective controlled dynamic parameters and spatial distribution of chemical signals in hydrogel scaffolds are critical for cell–cell communication, cell-scaffold interaction, and cell morphogenesis. Biomimetic hydrogels could be proposed for providing the supporting cells with spatiotemporally controlled chemical signals as tissue engineering scaffolds. These artificially designed hydrogels are found be helpful for clinically probing the temporally controlled growth factor-release abilities, spatially controlled conjugated bioactive molecules/motifs, and targeting delivery and reload properties for tissue engineering applications including exhibiting improved clinical characteristics like injectability, self-healing ability, stimulus-responsiveness and pro-remodeling features Multifunctional fibrous scaffolds have been also synthesized having high potential for bone regeneration which composed of poly d,l-lactide-co-trimethylene carbonate (PLMC) and worked as biomimicking attributes of poly d,l-lactideco-trimethylene carbonate nanofibers having improved efficacies and potency as scaffold materials for tissue repair and regeneration (**Figure 2**) [25]. Another new advanced technology based on cell membrane-covered or coated biomimetic nanovehicles for biomedical application has been seeking increasing attention involving membranes from red blood cells, platelets, leukocytes, tumor/cancer, and stem cells which are proposed as biomimetic coatings.

of nanoparticles for eluding the stimulated immune system to maintain their respective targeting capability. Biomimetic technology has also been incorporated in many robotics innovations to make robotic legs and feet for handicapped patients. Most recent, highly advanced biomimetic medical approach was reported for designing 5-degree-of-freedom robotic exoskeleton for upper limb therapy as most hi-tech rehabilitation robots by using CATIA software which inspired by the morphology of the bones and the muscle force transmission of the upper limbs [26, 27]. Scientists have been proposed various protocols for mimic the biological systems for achieving molecular scale control via self-assembly and directed assembly techniques via computerized fabrication and biochemical modification

**169**

**3. Conclusions**

*Clinical Approaches of Biomimetic: An Emerging Next Generation Technology*

with molecular precision to develop novel nanoscale devices to carry out diagnostic and therapeutic applications. Biomimetic technology has been adopted for designing and synthesis of a family of chiral and conformationally constrained involving preparation of a 160,000-member library of diverse tetramers via split-and-pool methods and from this library, a non-covalent ligand to the DNA-binding domain of p53 was invented for finding out its most feasible biomedical applications [27]. Nanozymes have been exploited in biomedicine and biomolecular detection which found to exhibit natural enzyme-mimicking catalytic activities to be used as specific nanocatalytic tumor therapy. The construction of an efficient biomimetic dual inorganic nanozyme-based nanoplatform is found to helpful for tumor microenvironment responsive nanocatalytic tumor therapy which triggers cascade catalytic reactions based on micro/submicron/nanosized Au and Fe3

NPs coloaded dendritic mesoporous silica nanoparticles. Various reported in-vitro and in-vivo clinical interpretations have found higher nanocatalytic-therapeutic efficient and safe with a desirable tumor-suppression rate (69.08%) based on their respective biocompatible composite nanocatalysts. Due to having observed high efficiency of in-vitro nanocatalytic therapy for killing cancer cells, the prolonged blood circulation, and potent tumor accumulation effect, the in vivo nanocatalytic therapeutic efficiency of DMSN-Au-Fe3O4 NPs was assessed against the 4 T1 breast

nanosystems have also been evaluated for further clinical translation assessments. Therefore, proposed biomimetic dual inorganic nanocomposite-triggered cascade reaction strategy for TME-responsive and effective nanocatalytic tumor therapy is found to accepted paradigm of toxin-free-drug endogenous and noninvasive nanocatalytic biomedicine by adopting multienzyme mimicking catalytic activities for tumor-specific therapies [28, 29]. Recently, Inflammatory eye diseases including dry eye disease, uveitis, allergic conjunctivitis, scleritis, glaucoma, retinopathy and Age-Related Macular Degeneration (AMD) are treated by using biomimetic based ophthalmic drug delivery of immunomodulatory agents to improve visionthreatening ill effects in subjected patients as safe and easy controlled-release of loaded formulation with improved patient compliance and treatment efficacy. This proposed biomimetic ophthalmic drug delivery practice has pacifying symptoms in subjected patients with negligible dangerous side effects [30–33]. Three dimensional nanofibrous extracellular matrix mimicking structures are proposed to be found suitable to be used as tissue engineering scaffolds composed of biochemically modified natural and synthetic polymers to develop more advanced biomedical tools and devices which have potential of replication of the biomineralization and

Hence, Biomimetic based technologies have been considered the most advanced alternative methods of chemically and bio-engineered drug delivery vehicles and devices. And, it needs lots of innovative inputs and related interpretations to make them more efficient and cost effective [36, 37]. Taken together, these findings indicate that biomimetics is becoming a dominant paradigm for robotics, materials science and other technological disciplines, with the potential for significant scientific, societal and economic impact over this decade and into the future. Hence, biomimicry is novel science stream which studies nature's models and further imitates or takes inspiration from these designs and their respective processes to solve human problems through engineering tools and artificial intelligence protocols (**Figure 3**) [37–39]. So, this innovative perspective fastened the scope of biomimetics (three

tumor xenograft on nude mice. Hence, these proposed DMSN-Au-Fe3

bone formation as well as tissue regeneration [34–36].

O4

composite

O4

*DOI: http://dx.doi.org/10.5772/intechopen.97148*

*Biodegradable and biomimetic elastomeric scaffolds (reproduced by Xue et al, 2017) [25].*

#### *Clinical Approaches of Biomimetic: An Emerging Next Generation Technology DOI: http://dx.doi.org/10.5772/intechopen.97148*

with molecular precision to develop novel nanoscale devices to carry out diagnostic and therapeutic applications. Biomimetic technology has been adopted for designing and synthesis of a family of chiral and conformationally constrained involving preparation of a 160,000-member library of diverse tetramers via split-and-pool methods and from this library, a non-covalent ligand to the DNA-binding domain of p53 was invented for finding out its most feasible biomedical applications [27]. Nanozymes have been exploited in biomedicine and biomolecular detection which found to exhibit natural enzyme-mimicking catalytic activities to be used as specific nanocatalytic tumor therapy. The construction of an efficient biomimetic dual inorganic nanozyme-based nanoplatform is found to helpful for tumor microenvironment responsive nanocatalytic tumor therapy which triggers cascade catalytic reactions based on micro/submicron/nanosized Au and Fe3 O4 NPs coloaded dendritic mesoporous silica nanoparticles. Various reported in-vitro and in-vivo clinical interpretations have found higher nanocatalytic-therapeutic efficient and safe with a desirable tumor-suppression rate (69.08%) based on their respective biocompatible composite nanocatalysts. Due to having observed high efficiency of in-vitro nanocatalytic therapy for killing cancer cells, the prolonged blood circulation, and potent tumor accumulation effect, the in vivo nanocatalytic therapeutic efficiency of DMSN-Au-Fe3O4 NPs was assessed against the 4 T1 breast tumor xenograft on nude mice. Hence, these proposed DMSN-Au-Fe3 O4 composite nanosystems have also been evaluated for further clinical translation assessments. Therefore, proposed biomimetic dual inorganic nanocomposite-triggered cascade reaction strategy for TME-responsive and effective nanocatalytic tumor therapy is found to accepted paradigm of toxin-free-drug endogenous and noninvasive nanocatalytic biomedicine by adopting multienzyme mimicking catalytic activities for tumor-specific therapies [28, 29]. Recently, Inflammatory eye diseases including dry eye disease, uveitis, allergic conjunctivitis, scleritis, glaucoma, retinopathy and Age-Related Macular Degeneration (AMD) are treated by using biomimetic based ophthalmic drug delivery of immunomodulatory agents to improve visionthreatening ill effects in subjected patients as safe and easy controlled-release of loaded formulation with improved patient compliance and treatment efficacy. This proposed biomimetic ophthalmic drug delivery practice has pacifying symptoms in subjected patients with negligible dangerous side effects [30–33]. Three dimensional nanofibrous extracellular matrix mimicking structures are proposed to be found suitable to be used as tissue engineering scaffolds composed of biochemically modified natural and synthetic polymers to develop more advanced biomedical tools and devices which have potential of replication of the biomineralization and bone formation as well as tissue regeneration [34–36].
